Points to consider in the manufacture and testing of monoclonal antibody products for human use.

Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [1997]
Description1 online resource (50 p.)
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS113624
Subjects

General noteTitle from title screen (viewed on June 9, 2009).
General note"February 28, 1997".
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references (p. 49-50).
Technical detailsMode of access: Internet at the FDA web site. Address as of 6/9/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/OtherRecommendationsforManufacturers/UCM153182.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:M 75

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available